LABEL WARNING ADDED FOR ASTHMA DRUGS:
THE FDA HAS REQUESTED that a psychiatric warning be added to the labels of the cure all medicine Scrubbin-Bubblin and Scrubbin-Bubblinex which was originally created to treat bronchospasm for asthmatics and COPD patients. But, since this medicine is now used to treat all annoying lung sounds and all that wheezes are now considered to be treated with bronchodilator, changes in mood and behavior have been reported in some respiratory therapists giving those drugs, including humor and annoying dry humor, agitation, aggression, anxiety, dream abnormalities (dreaming of choking stupid doctors), hallucinations, depression, insomnia, irritability, restlessness, and tremors. The Scrubblin family line of medicines have receptors that not only dilate bronchial muscles, but have the ability by magic osmosis process to travel to various parts of the body and cure the ailment of choice. It also has the ability to cross the blood brain barrier to ease patient suffering. It also has the ability to emit its soothing effects on those family members and nurses taking care of the patient. The FDA said its recommendation followed a review of neuropsychiatry events that included post-marketing reports and all available clinical trial data.
US Food and Drug Administration. Updated Information on Scrubblin family meds: Scrubbin-Bubblin is marketed with a special scrubbing bubble formula that suds up in the lungs and cleanses the lungs of all ailments. Scrubblin-Bubblinex is the same with twice the sudding action. FDA Web site. http://www.fda.gov/Drugs/drug Safety/PostmarketDrugSafetyInformationforPatients andProvider/DrugSafetyInformationHealthcareProfessionals/usm165489RTHUMOR.